Disease: Endometrial Carcinoma
Source: ALL
Variant Gene DSI v DPI v Chr Position Consequence Alleles Class AF EXOME AF GENOME Num. diseases
rs3819102
ENOSF1
0.827 0.120 18 675307 intron variant A/G snv 4.5E-02 3.6E-02 8
rs397517202
PIK3CA
0.851 0.320 3 179234230 missense variant A/G snv 4
rs4430796
HNF1B
0.790 0.280 17 37738049 intron variant A/G snv 0.52 14
rs4851527
IL1R2
0.790 0.160 2 102005914 intron variant A/G snv 0.63 7
rs4994
ADRB3
0.578 0.640 8 37966280 missense variant A/G snv 0.11 9.2E-02 65
rs771432878
CYP1A1
0.925 0.080 15 74723013 missense variant A/G snv 4.0E-06 3.5E-05 2
rs79575945
ESR1
0.925 0.080 6 151837712 intron variant A/G snv 7.9E-02 2
rs9261204
ZNRD1ASP
0.790 0.200 6 30037466 intron variant A/G snv 0.17 9
rs9340799
ESR1
0.583 0.680 6 151842246 intron variant A/G snv 0.32 62
rs1045642
ABCB1
0.456 0.840 7 87509329 synonymous variant A/G;T snv 0.50 214
rs121913279
PIK3CA
0.526 0.560 3 179234297 missense variant A/G;T snv 4.0E-06; 4.0E-06 101
rs1219648
FGFR2
0.716 0.320 10 121586676 intron variant A/G;T snv 17
rs3020449
ESR2
0.807 0.200 14 64306674 intron variant A/G;T snv 10
rs5275
PTGS2
0.583 0.560 1 186673926 3 prime UTR variant A/G;T snv 55
rs6478974
TGFBR1
0.851 0.120 9 99112121 intron variant A/G;T snv 4
rs743572
CYP17A1
0.672 0.360 10 102837395 5 prime UTR variant A/G;T snv 0.40; 8.1E-06 24
rs10502289
ENOSF1
0.925 0.080 18 676789 intron variant A/T snv 0.15 2
rs4987886
ATM
0.925 0.080 11 108225326 5 prime UTR variant A/T snv 3.0E-02 2
rs1056827
CYP1B1 ; CYP1B1-AS1
0.683 0.400 2 38075034 missense variant C/A snv 0.32 0.35 24
rs2736100
TERT
0.550 0.880 5 1286401 3 prime UTR variant C/A snv 0.52 83
rs6443624
PIK3CA
0.776 0.200 3 179179886 intron variant C/A snv 0.30 8
rs7679673 0.677 0.440 4 105140377 intron variant C/A snv 0.50 28
rs889312 0.732 0.360 5 56736057 regulatory region variant C/A snv 0.69 14
rs1042838
PGR
0.742 0.240 11 101062681 missense variant C/A;G snv 0.13; 4.0E-06 12
rs4245739
MDM4
0.708 0.360 1 204549714 3 prime UTR variant C/A;G snv 0.77; 6.2E-06 21